Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

The A-List: 2008's Trend Shaping Series A Financings

This article was originally published in Start Up

Executive Summary

Despite a miserable economy, new company formation continues apace. In biotech, recapitalizations and structured deals featured prominently; in diagnostics, interest remains strong even if rounds in 2008 were down from last year's highs; in devices, small and regional VCs have filled the void left by brand-name investors.
Advertisement

Related Content

The A-List: 2009's Trend-Shaping Series A Financings
Biopharma in 2008: What a Difference an Economic Crisis Makes
Sequenom Is Improving Prenatal Screening, in Steps
Private Biotech M&A Review: Has the Market Lost Steam?
Thriving When The Device IPO Window Closes
Exploiting Autophagy to Kill Cancer Cells
Boston Scientific Shuffles and Sells in Bid to Right Ship
Alzheimer's R&D: Tweaking Venture's Risk-Reward Ratio
Women's Health: A Growing Market for Diagnostic Players
Borean Pharma AS

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC091686

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel